KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new interim results from its KONFIDENT-KID clinical trial evaluating EKTERLY® (sebetralstat) for the on-demand treatment of hereditary ...
Long-term use of donidalorsen helps prevent swelling attacks in patients with hereditary angioedema (HAE), according to the results of a 4-year open-label extension (OLE) study (NCT04307381) published ...
The FDA has granted Fast Track designation to BW-20805, an investigational small interfering RNA therapy for hereditary angioedema.
Angiotensin-converting enzyme inhibitors (ACEi) are the leading cause of drug-induced angioedema in the USA, with an ...
A new report suggests patients with obesity and chronic spontaneous urticaria (CSU) tend to be older when diagnosed with the latter condition, and are also less likely to respond to omalizumab (Xolair ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Deucrictibant is an orally administered bradykinin B2 ...
Hereditary angioedema (HAE) is a rare genetic syndrome caused by a deficiency in functional C1 inhibitor that results in recurrent episodes of nonpruritic swelling of the hands, feet, arms, legs, ...
New York, USA, May 06, 2025 (GLOBE NEWSWIRE) -- Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses ...
October 17, 2012 (Boston, Massachusetts) — The risk of the potentially life-threatening side effect angioedema differs between different classes of drugs that inhibit the renin-angiotensin-aldosterone ...
Angioedema is basically swelling of the deeper layers of the skin. This is due to accumulation of fluids caused by an allergic reaction. Pathogenesis of the types of angioedema has been studied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results